Japan, Jan. 23 -- CHUGAI PHARMACEUT CO LTD has got intellectual property rights for 'PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT.' Other related details are as follows:

Application Number: JP,2024-213173

Category (FI): A61P43/00,111,C07D471/04,106@H,A61P25/16,A61P25/28,A61K31/444,A61K31/5377,A61K31/437,A61K31/506,A61K31/4725,A61K31/5386,C07D519/00,311,C07D471/04,A61K31/4709,A61P3/10,A61K31/496,A61P3/04,A61P3/06,A61P9/12,A61P9/10,101,A61P9/00,A61P9/10,A61P1/16,A61P29/00

Stage: Grant (IP right document published.)

Filing Date: Dec. 6, 2024

Publication Date: March 11, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....